国际中医中药杂志
國際中醫中藥雜誌
국제중의중약잡지
INTERNATIONAL JOURNAL OF TRIDITIONAL CHINESE MEDICINE
2009年
5期
429-430
,共2页
肠易激综合征%中药%痛泻要方
腸易激綜閤徵%中藥%痛瀉要方
장역격종합정%중약%통사요방
Irritable Bowel Syndrome: Traditional Chinese medicine%TongXieYaoFang
目的 观察自拟痛泻药方为主治疗肠易激综合征(irritable bowel syndrome,IBS)的临床疗效.方法 将83例IBS患者随机分为两组,对照组38例口服曲美布汀200 mg、培非康420 mg,3次/d:治疗组45例,在对照组治疗的基础上加服自拟痛泻药方,两组均治疗4周为1个疗程.结果 治疗组总有效率为93.3%,对照组总有效率为71.1%,两组比较,差异有统计学意义(X2=7.2938,P<0.01).结论 中药自拟痛泻要方联合西药治疗IBS有效.
目的 觀察自擬痛瀉藥方為主治療腸易激綜閤徵(irritable bowel syndrome,IBS)的臨床療效.方法 將83例IBS患者隨機分為兩組,對照組38例口服麯美佈汀200 mg、培非康420 mg,3次/d:治療組45例,在對照組治療的基礎上加服自擬痛瀉藥方,兩組均治療4週為1箇療程.結果 治療組總有效率為93.3%,對照組總有效率為71.1%,兩組比較,差異有統計學意義(X2=7.2938,P<0.01).結論 中藥自擬痛瀉要方聯閤西藥治療IBS有效.
목적 관찰자의통사약방위주치료장역격종합정(irritable bowel syndrome,IBS)적림상료효.방법 장83례IBS환자수궤분위량조,대조조38례구복곡미포정200 mg、배비강420 mg,3차/d:치료조45례,재대조조치료적기출상가복자의통사약방,량조균치료4주위1개료정.결과 치료조총유효솔위93.3%,대조조총유효솔위71.1%,량조비교,차이유통계학의의(X2=7.2938,P<0.01).결론 중약자의통사요방연합서약치료IBS유효.
Objective To study the effects of treating irritable bowel syndrome (IBS) with modified TongXieYaoFang. Methods 83 IBS patients were randomly recruited into a treatment group (45 patients) and a control group (38 patients). In the control group, Trimebutine, 200mg, and Bifid triple viable capsule, 420mg, 3 times/day was given orally to the patients, while on the basis of that, the treatment group was administrated with modified TongXieYaoFang in addition. Both groups were treated for one course of 4 weeks. Results The total effective rate of the treatment group and the control group was 93.3% and 71.1% respectively, showing significant difference between the two groups (X2=7.2938, P<0.01 ). Conclusion TongXieYaoFang combined with western medicine is effective in treating IBS.
